Veterinary Medicines

ReproCyc PRRS EU lyophilisate and solvent for suspension for injection for pigs

Authorised
  • Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
  • Water for injection
Download as PDF

Product identification

Medicine name:
ReproCyc PRRS EU, liofilizatas ir skiediklis injekcinei suspensijai ruošti kiaulėms
ReproCyc PRRS EU lyophilisate and solvent for suspension for injection for pigs
Active substance:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
  • Water for injection
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
    10000000.00
    tissue culture infective dose 50
    /
    1.00
    Dose
  • Water for injection
    1.00
    other
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 25 lyophilisate vials of 200 ml (100 doses) and Cardboard box of 25 solvent vials of 200 ml (100 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 25 lyophilisate vials of 100 ml (50 doses) and Cardboard box of 25 solvent vials of 100 ml (50 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 25 lyophilisate vials of 20 ml (10 doses) and Cardboard box of 25 solvent vials of 20 ml (10 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 12 lyophilisate vials of 200 ml (100 doses) and Cardboard box of 12 solvent vials of 200 ml (100 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 12 lyophilisate vials of 100 ml (50 doses) and Cardboard box of 12 solvent vials of 100 ml (50 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 12 lyophilisate vials of 20 ml (10 doses) and Cardboard box of 12 solvent vials of 20 ml (10 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 1 lyophilisate vial of 200 ml and 1 solvent vial of 200 ml (100 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 1 lyophilisate vial of 100 ml and 1 solvent vial of 100 ml (50 doses).
  • Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 1 lyophilisate vial of 20 ml and 1 solvent vial of 20 ml (10 doses).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
  • LT/2/15/2273/001-003
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0444/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Estonia
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 27/02/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."